id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3059856,3cefa065-7ccb-4d4b-9ca0-e8108ea2e77c,Q3,"MARSHALL & POPP, LLC",401105121,"GENENTECH, INC.",2023,third_quarter,CPT,"Issues related to intellectual property and patent reform, including: S.150, Affordable Prescriptions for Patients Act; S.79, Interagency Patent Coordination and Improvement Act; S.113, Prescription Pricing for the People Act; S.142, Preserve Access to Affordable Generics and Biosimilars Act; and S.148, Stop STALLING Act.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2023-10-19T09:48:22-04:00